Analysts Offer Insights on Healthcare Companies: InMode (INMD), Fortrea Holdings Inc. (FTRE) and Lexeo Therapeutics, Inc. (LXEO)
Fortrea Holdings Analyst Ratings
Fortrea Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), Fortrea Holdings Inc. (FTRE) and Cellectis SA (CLLS)
Fortrea Holdings Analyst Ratings
Maintaining Hold on Fortrea Holdings Amidst Long-Term Recovery and Current Industry Challenges
Fortrea Holdings Analyst Ratings
Fortrea Holdings Analyst Ratings
Fortrea Holdings Analyst Ratings
Baird Upgrades Fortrea Holdings to Outperform, Lowers Price Target to $36
Fortrea Holdings Analyst Ratings
Baird Initiates Coverage On Fortrea Holdings With Neutral Rating, Announces Price Target of $43
Fortrea Holdings Analyst Ratings
Analysts Have Conflicting Sentiments on These Healthcare Companies: Incyte (INCY), Fortrea Holdings Inc. (FTRE) and Abbott Labs (ABT)
Fortrea Holdings Analyst Ratings
Fortrea Holdings Analyst Ratings
Fortrea Holdings Analyst Ratings
Jefferies Initiates Coverage On Fortrea Holdings With Buy Rating, Announces Price Target of $44
Fortrea Holdings Analyst Ratings
Analysts Conflicted on These Healthcare Names: Evotec AG (EVO), Collegium Pharmaceutical (COLL) and Fortrea Holdings Inc. (FTRE)